Udall Project 1 Aim 4

Launched by UNIVERSITY OF MINNESOTA · Oct 2, 2022

Keywords

ClinConnect Summary

The Udall Project 1 Aim 4 clinical trial is studying how certain brain circuits help with movement and thinking in people with Parkinson's Disease who have received Deep Brain Stimulation (DBS). The researchers want to learn more about the connections in the brain during rest and movement, which could lead to better ways to customize DBS treatments in the future. This could potentially improve the benefits of DBS for both motor skills and cognitive function.

To participate, individuals must be at least 21 years old, already have a DBS system implanted, and have been diagnosed with idiopathic Parkinson's Disease. They should also have had a specific type of brain scan (7T imaging) done previously. However, those with other serious neurological disorders, dementia, or who are pregnant cannot join. Participants can expect to contribute to important research that may enhance how DBS is used, helping to improve the quality of life for those living with Parkinson's Disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Implanted with a DBS system
• • Existing 7T imagery (either done as standard-of-care or done as part of Noam Harel's study, IRB #1210M22183)
• • Diagnosed with idiopathic Parkinson's Disease
• • Minimum age 21 years
• Exclusion Criteria:
• • Other significant neurological disorder, as determined by PI
• • Diagnosis of dementia
• • Pregnant